Symbol Name ID |
Cd109
CD109 antigen MGI:2445221 |
Reference
|
J:342844 Harvey AB, Wolters RA, Deepe RN, Tarolli HG, Drummond JR, Trouten A, Zandi A, Barth JL, Mukherjee R, Romeo MJ, Vaena SG, Tao G, Muise-Helmericks R, Ramos PS, Norris RA, Wessels A, Epicardial deletion of Sox9 leads to myxomatous valve degeneration and identifies Cd109 as a novel gene associated with valve development. J Mol Cell Cardiol. 2023 Nov 5;186:16-30 |
Age | E14.5 | E15.5 | E16.5 | E17.5 | P |
Immunohistochemistry (section) | |||||
In situ RNA (section) | |||||
Immunohistochemistry (whole mount) | |||||
In situ RNA (whole mount) | |||||
In situ reporter (knock in) | |||||
Northern blot | |||||
Western blot | |||||
RT-PCR | |||||
cDNA clones | |||||
RNase protection | |||||
Nuclease S1 | |||||
Primer Extension |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|